Zinc acetate
Sponsors
National Center for Research Resources (NCRR), Nobelpharma, Makerere University, University of Michigan, University of Maryland, Baltimore
Conditions
Bronchopulmonary DysplasiaCOVID-19CardiomyopathiesDiabetesDystonia, FocalGrowth FailureHIVHIV Infection
Phase 1
Phase 2
Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers
CompletedNCT02868151
Start: 2016-08-31End: 2018-10-31Updated: 2019-03-20
An Outpatient Study Investigating Non-prescription Treatments for COVID-19
TerminatedNCT04621149
Start: 2020-11-15End: 2022-03-31Updated: 2022-09-30
Phase 3
Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.
CompletedNCT00212368
Start: 2004-10-31End: 2005-12-31Updated: 2010-09-10
The Efficacy of Zinc as Adjunct Therapy in the Treatment of Severe Pneumonia in Children
CompletedNCT00373100
Start: 2006-09-30End: 2007-03-31Target: 328Updated: 2009-07-07
Phase 4
Unknown Phase
Nutrigenomics of Zinc Supplementation in Insulin Secretion and Diabetes
CompletedNCT00981448
Start: 2009-09-30End: 2012-04-30Updated: 2022-01-20
Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia
TerminatedNCT03532555
Start: 2018-03-22End: 2022-08-25Updated: 2023-05-09
Oral Zinc Supplementation to Enhance Botulinum Neurotoxin Response
CompletedNCT05095493
Start: 2013-01-01End: 2014-10-31Updated: 2021-10-27
Zn Supplementation in HIV Immunological Non Responders
RecruitingNCT06612554
Start: 2025-01-02End: 2026-12-01Target: 120Updated: 2026-04-16